Severe COVID-19 Infection Management in a Patient with Mild Haemophilia-A Case Report.
Hematol Rep
; 14(2): 103-107, 2022 Mar 30.
Article
in English
| MEDLINE | ID: covidwho-1809836
ABSTRACT
Patients with haemophilia present a significant challenge when admitted into the intensive care unit. To prevent haemorrhagic complications related to the infection or due to invasive procedures factor (F) VIII/IX must be substituted. As thromboembolic complications are frequent among critically ill COVID-19 patients, thromboprophylaxis is also applied to patients with haemophilia. This requires careful monitoring of FVIII/IX activity as well as other haemostatic parameters, such as D-dimer and antiXa. We describe a 44-year old patient with mild haemophilia A (FVIII activity of 6%), who required a prolonged intensive care unit stay due to a severe SARS-CoV-2 infection. FVIII was substituted via boluses, and dalteparin was given according to recommendations. The patient successfully recovered from the disease.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Hematol Rep
Year:
2022
Document Type:
Article
Affiliation country:
Hematolrep14020015
Similar
MEDLINE
...
LILACS
LIS